Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jiangyuan, Du"'
Publikováno v:
Journal of Immunology Research, Vol 2022 (2022)
Dendritic cell- (DC-) based vaccination has emerged as a promising antitumour immunotherapy. However, overcoming immune tolerance and immunosuppression in the tumour microenvironment (TME) is still a great challenge. Recent studies have shown that Ro
Externí odkaz:
https://doaj.org/article/89b8fcf9590f438988fb5e55a96d5c0c
Publikováno v:
Journal of immunology research. 2022
Dendritic cell- (DC-) based vaccination has emerged as a promising antitumour immunotherapy. However, overcoming immune tolerance and immunosuppression in the tumour microenvironment (TME) is still a great challenge. Recent studies have shown that Ro
Autor:
Jun Qin, Min Jiang, Yue Li, Yingying Wang, Guowen Lin, Din-wei Ye, Mingang Hao, Vladimir Korinek, Xueqing Sun, Jiangyuan Du, Jinglong Wang, Kun Chang, Jianhua Wang, Lidong Zu, Yufeng Ding
Publikováno v:
The Journal of Pathology. 242:409-420
Metastatic disease is the leading cause of death due to prostate cancer (PCa). Although the hypermethylated in cancer 1 (HIC1) gene has been observed to be epigenetically modified in PCa, its intrinsic role and mechanism in PCa metastasis still remai
Autor:
Mingang, Hao, Yue, Li, Jinglong, Wang, Jun, Qin, Yingying, Wang, Yufeng, Ding, Min, Jiang, Xueqing, Sun, Lidong, Zu, Kun, Chang, Guowen, Lin, Jiangyuan, Du, Vladimir, Korinek, Din-Wei, Ye, Jianhua, Wang
Publikováno v:
The Journal of pathology. 242(4)
Metastatic disease is the leading cause of death due to prostate cancer (PCa). Although the hypermethylated in cancer 1 (HIC1) gene has been observed to be epigenetically modified in PCa, its intrinsic role and mechanism in PCa metastasis still remai